Edition:
India

Ignyta Inc (RXDX.OQ)

RXDX.OQ on NASDAQ Stock Exchange Capital Market

15.60USD
2:29am IST
Change (% chg)

$0.35 (+2.30%)
Prev Close
$15.25
Open
$15.50
Day's High
$15.70
Day's Low
$15.35
Volume
92,996
Avg. Vol
257,497
52-wk High
$18.25
52-wk Low
$4.65

Select another date:

Wed, Nov 8 2017

BRIEF-Ignyta announces new data highlighting immune modulation of RXDX-106 at the society for immunotherapy of cancer meeting

* Ignyta announces new data highlighting immune modulation of RXDX-106 at the society for immunotherapy of cancer (sitc) meeting Source text for Eikon: Further company coverage:

BRIEF-Ignyta Inc files for potential mixed shelf offering; size not disclosed

* Ignyta Inc files for potential mixed shelf offering; size not disclosed - SEC filing‍​ Source text: (http://bit.ly/2gt6zxh) Further company coverage:

BRIEF-Ignyta receives EMA PRIME designation for entrectinib in NTRK fusion-positive solid tumors

* Ignyta receives European Medicines Agency prime designation for entrectinib in NTRK fusion-positive solid tumors Source text for Eikon: Further company coverage:

BRIEF-Ignyta Inc - ‍announced new preclinical data for RXDX-106​

* Ignyta Inc - ‍in study, researchers demonstrated immune-mediated, single-agent anti-tumor activity of RXDX-106 in multiple tumor models​ Source text for Eikon: Further company coverage:

BRIEF-Ignyta Q2 loss per share $0.56

* Ignyta announces second quarter 2017 company highlights and financial results

BRIEF-Ignyta receives FDA orphan drug designation for entrectinib

* Ignyta receives FDA orphan drug designation for entrectinib for treatment of NTRK fusion-positive solid tumors

Select another date: